Blood News and Research

RSS

Groundbreaking trial aims for precise dietary data collection

Scientists are recruiting adults from across the UK to take part in a groundbreaking trial to accurately track what they eat and drink in their daily lives.

9 Feb 2026

Most statin side effects are not backed by trials

Research indicates that many statin therapy side effects are not supported by evidence, suggesting a need for revised labeling to improve treatment decisions.

9 Feb 2026

Public health workers are quitting over assignments to Guantánamo

Rebekah Stewart, a nurse at the U.S. Public Health Service, got a call last April that brought her to tears. She had been selected for deployment to the Trump administration's new immigration detention operation at Guantánamo Bay, Cuba.

9 Feb 2026

Late sleepers have higher heart risk, and it's mostly preventable

Researchers explore the association between an individual’s chronotype and cardiovascular risk.

9 Feb 2026

Cellares to expand automated manufacturing to gene-edited stem cell therapies

Cellares, the first Integrated Development and Manufacturing Organization (IDMO), today announced a collaboration with the Stanford Center for Definitive and Curative Medicine (CDCM) and Stanford Innovative Medicines Accelerator (IMA) to automate manufacturing and release testing for gene-edited hematopoietic stem cell (HSC) therapies, expanding the application of Cellares' automation platforms beyond T cell therapies into a new cell modality.

From Cellares 8 Feb 2026

UK air ambulance critical care expands but unequal access still limits lifesaving treatment

A national UK survey found physician-based helicopter emergency medical services have expanded substantially since 2009, with more teams and improved overnight coverage. However, geographic and time-of-day disparities persist, and variation in funding, staffing, and interventions continues to affect equitable access to advanced prehospital care.

8 Feb 2026

AI stethoscope doubles detection of serious valve disease in primary care study

A prospective primary care study found that an AI-enabled digital stethoscope substantially improved sensitivity for detecting clinically significant valvular heart disease compared with standard auscultation. The technology identified more previously undiagnosed moderate-to-severe disease but showed reduced specificity, highlighting a trade-off between earlier detection and potential false positives.

8 Feb 2026

Novel neuroprotective drug improves recovery after acute ischemic stroke

Stroke patients treated intravenously with loberamisal, a novel neuroprotective medication, daily for 10 days and starting within 48 hours of stroke symptoms, had better recovery than patients who received a placebo, according to a preliminary late-breaking science presentation at the American Stroke Association's International Stroke Conference 2026.

7 Feb 2026

Mesothelial cells enable rapid invasion and spread of ovarian cancer

Ovarian cancer kills more women than any other gynecological cancer. Most patients receive their diagnosis only after the disease spreads throughout the abdomen.

7 Feb 2026

Optical tissue monitoring predicts dialysis-related fluid instability

For the millions of people living with end‑stage kidney disease, hemodialysis is more than a medical procedure, it is a thrice‑weekly lifeline that keeps the body's chemistry in balance.

7 Feb 2026

Moderate exercise lowers atrial fibrillation recurrence after ablation

New research from CU Anschutz scientists suggests that staying physically active after heart rhythm treatment may significantly reduce the risk of atrial fibrillation (AF) returning, offering patients a simple, low-cost way to support long-term heart health.

7 Feb 2026

Cholesterol transporter ABCA1 boosts macrophage-driven cancer immunity

In recent years, cancer researchers have made major breakthroughs by using the body's immune system to fight cancer. One of the most promising approaches, known as immune checkpoint blockade, works by releasing molecular "brakes" on T cells.

7 Feb 2026

Gut bacteria use formic acid as an electron taxi

Among the many trillions of microorganisms in the human gut is Blautia luti. Like many gut bacteria, it metabolizes indigestible dietary components, such as fiber in the form of carbohydrates.

7 Feb 2026

RNA micelles enable targeted chemotherapy without immune toxicity

A new study in mice hints at the potential to use tiny particles made with RNA molecules to deliver chemotherapy drugs and other therapies directly to tumors, killing cancer cells without generating an immune response or toxicity-related side effects.

7 Feb 2026

4D-printed vascular stents expand naturally at body temperature

Cardiovascular diseases constitute a major global health concern. Various complications that affect normal blood flow in arteries and veins, such as stroke, blood clot formation in veins, blood vessel rupture, and coronary artery disease, often require vascular treatments.

6 Feb 2026

AI predicts blood transfusion needs for trauma patients before hospital arrival

Severe bleeding is one of the most common and preventable causes of death after traumatic injury, yet currently available tools have poor ability to determine which patients urgently need blood transfusions.

6 Feb 2026

Rapid malaria resistance evolution in Sudanese Coptic populations

The study published in PNAS sets out how, in just 1,500 years, the Copts have acquired a genetic variant that protects them from contracting malaria after mixing with other Sudanese populations.

6 Feb 2026

Investigational anti-clotting drug reduces risk of second ischemic stroke without bleeding concerns

An investigational anti-clotting medication, asundexian, demonstrated a reduction in the risk of a second ischemic (clot-caused) stroke without raising bleeding concerns, according to a preliminary late-breaking science presentation at the American Stroke Association's International Stroke Conference 2026.

6 Feb 2026

Triple negative breast cancer cells use new strategy to boost metastatic ability

Researchers at Baylor College of Medicine have uncovered a strategy that triple negative breast cancer (TNBC) cells use to boost their ability to metastasize, or spread to other organs.

6 Feb 2026

Hormonal contraceptives show differing heart risks among stressed women

Antonia Seligowski, PhD, of the Neurocardiac Effects of Stress & Trauma Laboratory within the Department of Psychiatry at Mass General Brigham, is the senior author of a paper published in JAMA Network Open, "Hormonal contraceptive use, stress disorders, and cardiovascular and thrombotic risk in women."

5 Feb 2026